A new study has found that weight loss injections, such as GLP-1 drugs, are linked to a significant drop in alcohol-related hospital admissions, with researchers reporting a reduction of around 60%. The finding adds to a growing body of evidence suggesting that these medications, originally developed to treat diabetes and obesity, may also curb alcohol cravings and problem drinking, a side benefit that could have wider implications for how alcohol addiction is treated.

The full details of the study's methodology, sample size and the researchers behind it were not available in the article text supplied. However, the reported 60% fall in alcohol-related hospitalisations underscores mounting interest among scientists and clinicians in the potential of weight loss jabs to influence behaviours beyond eating, including drinking habits, as more data emerges from real-world use of these drugs.